Phospho-P21CIP1 (T145) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Phospho-P21CIP1 (T145) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Phospho-P21CIP1 (T145) |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 0.5 |
| Applications | Western Blot (WB), Dot Blot (DB), ELISA (EIA), Immunohistochemistry (IHC) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This P21CIP1 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding T145 of human P21CIP1. P21CIP1 is a potent cyclin-dependent kinase inhibitor. This protein binds to and inhibits the activity of cyclin-CDK2 or -CDK4 complexes, and thus functions as a regulator of cell cycle progression at G1. Expression is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. P21CIP1 can interact with proliferating cell nuclear antigen (PCNA), a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage |
| Immunogen | n/a |
| Other Names | [Cyclin-dependent kinase inhibitor 1; CDK-interacting protein 1; Melanoma differentiation-associated protein 6; MDA-6; p21; CDKN1A; CAP20; CDKN1; CIP1; MDA6; PIC1; SDI1; WAF1] |
| Gene, Accession # | [CDKN1A], Gene ID: 1026, NCBI: NP_000380.1, UniProt: P38936 |
| Catalog # | MBS9203875 |
| Price | $165, $370 |
| Order / More Info | Phospho-P21CIP1 (T145) Antibody from MYBIOSOURCE INC. |
| Product Specific References | Scott, S.A., et al., Leuk. Res. 28(12):1293-1301 (2004). Amini, S., et al., J. Biol. Chem. 279(44):46046-46056 (2004). Chen, T., et al., Cancer Res. 64(20):7412-7419 (2004). Sieburg, M., et al., J. Virol. 78(19):10399-10409 (2004). Giraud, S., et al., Oncogene 23(44):7391-7398 (2004). |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies